UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 6, 2003
------------------
MERCK & CO., Inc.
--------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
--------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-3305 22-1109110
----------------------------------- -----------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100
--------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (908) 423-1000
---------------------
Item 7. Financial Statements and Exhibits
-------------------------------------------
(c) Exhibits
--------
Exhibit 99.1 Notice to Executive Officers of Merck & Co., Inc. Filed with
concerning a blackout period under certain this document
Company benefit plans
Exhibit 99.2 Notice to Directors of Merck & Co., Inc. Filed with
concerning a blackout period under certain this document
Company benefit plans
Item 11. Temporary Suspension of Trading Under Registrant's Employee Benefit
Plans.
----------------------------------------------------------------------------
On August 4, 2003, in connection with the spin-off (the "Spin-off") of
Medco Health Solutions, Inc. ("Medco Health Solutions"), the Board of
Directors of Merck & Co., Inc. (the "Company") declared a dividend of
shares of Medco Health Solutions to the shareholders of the Company.
The distribution date for the dividend, and the date of the Spin-off,
will be August 19, 2003. On August 6, 2003, the Company sent notices to
its executive officers and directors notifying them that in connection
with the Spin-off there would be a "blackout" period under the
Company's stock option plans, savings plans and deferral program. The
notices to the executive officers and directors are filed as Exhibits
to this Form 8-K. The Company received the notice pursuant to section
101(i)(2)(E) of the Employee Retirement Income Security Act of 1974 on
August 5, 2003.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MERCK & CO., Inc.
Date: August 6, 2003 By: /s/ Nancy V. Van Allen
-----------------------------------
NANCY V. VAN ALLEN
Senior Assistant Secretary
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Notice to Executive Officers of Merck & Co., Inc. concerning a blackout period
under certain Company benefit plans
99.2 Notice to Directors of Merck & Co., Inc. concerning a blackout period under
certain Company benefit plans